A review of patient self-report tools for chemotherapy-induced nausea and vomiting

Supportive Care in Cancer

Volumn 16, Issue 11, 2008, Pages 1213-1229

  Brearley, Sarah G ^a   Clements, Caroline V ^a   Molassiotis, Alex ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chemotherapy; Nausea; Retching; Self report tool; Vomiting

Indexed keywords

CHEMOTHERAPY INDUCED EMESIS; CINAHL; E-MAIL; ELECTRONIC MEDICAL RECORD; EMBASE; HUMAN; MEDLINE; PRIORITY JOURNAL; PSYCHOMETRY; PSYCINFO; QUALITY OF LIFE; RELIABILITY; REVIEW; SELF EVALUATION; SELF REPORT; UNPLEASANT SENSATION; VALIDATION STUDY;

ANTINEOPLASTIC AGENTS; HUMANS; NAUSEA; NEOPLASMS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; VOMITING;

EID: 53949088237     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0428-y     Document Type: Review

References (63)

1. NK Aaronson S Ahmedzai B Bergman M Bullinger A Cull NJ Duez A Filiberti H Flechtner SB Fleishman JC de Haes S Kaasa MC Klee D Osoba D Razavi PB Rofe S Schraub KC Sneeuw M Sullivan D Takeda 1993 The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 365 376
2. Alves-Guerreiro J, Lowe-Strong AS, Walsh DM, Lopes BC, Costa R, Rosado R, Monforte E, Rolo T, Projecto J, Ferreira M (2003) Development of a Portuguese version of the Morrow Assessment of Nausea and Emesis (MANE) questionnaire: moving physical therapy forward [abstract]. 14th International World Confederation for Physical Therapy Congress
3. K Bergkvist Y Wengström 2006 Symptom experience during chemotherapy treatment-with focus on nausea and vomiting Eur J Oncol Nurs 10 21 29
4. CLM Carnrike Jr MP Carey 1990 Assessing nausea and vomiting in adult chemotherapy patients: review and recommendations Ann Behav Med 12 79 85
5. CLM Carnrike PJ Brantley B Bruce S Faruqui FM Gresham RR Buss TB Cocke 1988 Test-restest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy- related nausea and vomiting J Psychopathol Behav Assess 10 107 116
6. F-H Chou KC Avant S-H Kuo HF Cheng 2005 Assessing the psychometric and language equivalency of the Chinese versions of the index of nausea, vomiting and retching, and the prenatal self-evaluation questionnaire Kaohsiung J Med Sci 21 314 321
7. MA Crucitt W Hyman T Grote W Tester S Madajewicz S Yee A Wentz D Griffin TV Parasuraman J Bryson 1996 Efficacy and tolerability or oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphomide-based chemotherapy and maintenance of health-related quality of life Clin Ther 18 778 788
8. AS Coates S Abraham SB Kaye T Sowerbutts C Frewin R Fox M Tattersall 1983 On the receiving end: patient perception of the side effects of chemotherapy Eur J Cancer Clin Oncol 19 203 208
9. M de Boer-Dennert R de Wit PI Schmitz J Djontono V v Beurden G Stoter J Verweij 1997 Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists Br J Cancer 76 1055 1061
10. GM Decker ES DeMeyer DL Kisko 2006 Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy J Support Oncol 4 35 41
11. DeGroot T, Einhorn L, Brames J, Roth BJ, Dreicer R, Nichols C, Bubalo J (2006) Multiple-day Palonosetron antiemetic regimen is safe and effective for preventing chemotherapy-induced nausea and vomiting in patients receiving 5-day Cisplatin for testicular cancer. Presented at Chicago Supportive Oncology Conference Sept 27-30
12. SL Dibble J Chapman KA Mack A Shih 2000 Acupressure for nausea: results of a pilot study Oncol Nurs Forum 27 41 47
13. SL Dibble J Israel B Nussey K Casey J Luce 2003 Delayed chemotherapy-induced nausea in women treated for breast cancer Oncol Nurs Forum 30 40 47
14. PA Farley CL Dempsey AA Shillington C Kulis-Robitaille K Colgan G Bernstein 1997 Patients' self-reported functional status after granisetron or ondansetron therapy to prevent chemotherapy-induced nausea and vomiting at six cancer centers Am J Health-Syst Pharm 54 2478 2482
15. EK Fromme KM Eilers M Mori Y-C Hsieh TM Beer 2004 How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient- reported symptoms form the quality-of-life questionnaire C30 J Clin Oncol 22 3485 3490
16. MR Fu V Rhodes B Xu 2002 The Chinese translation of the index of nausea, vomiting and retching Cancer Nurs 25 134 140
17. A Glaus C Knipping R Morant C Bohme B Lebert F Beldermann B Glawogger PF Ortega A Husler R Deuson 2004 Chemotherapy-induced nausea and vomiting in routine practice: a European perspective Support Care Cancer 12 708 715
18. AG Gift A Jablonski M Stommel WC Given 2004 Symptom clusters in elderly patients with lung cancer Oncol Nurs Forum 31 203 209
19. AM Griffin PN Butow AS Coates AM Childs PM Ellis SM Dunn MHN Tattersall 1996 On the receiving end v: patient perceptions of the side effects of chemotherapy in 1993 Ann Oncol 7 189 195
20. SM Grunberg RR Deuson P Mavros O Geling M Hansen G Cruciani B Daniele G De Pouvourville EB Rubenstein G Daugaard 2004 Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer 100 2261 2268
21. PJ Hesketh RJ Gralla A du Bois M Tonato 1998 Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity Support Care Cancer 6 221 227
22. PJ Hesketh SM Grunberg RJ Gralla DG Warr F Roila R de Wit SP Chawla AD Carides J Ianus ME Elmer JK Evans K Beck S Reines KJ Horgan 2003 The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin J Clin Oncol 21 4112 4119
23. PJ Hesketh MG Kris SM Grunberg T Beck JD Hainsworth G Harker AM Aapro D Gandara C Lindley 1997 Proposal for classifying the acute emetogenicity of cancer chemotherapy J Clin Oncol 15 103 109
24. JT Hickok JA Roscoe GR Morrow DK King JN Atkins TR Fitch 2003 Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5 hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community Cancer 1 2880 2886
25. JT Hickock JA Roscoe GR Morrow RM Stern B Yang PJ Flynn HE Kirshner R Rosenbluth 1999 Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings Cancer 86 64 71
26. N Honea J Breant SL Beck 2007 Treatment related symptom cluster Semin Oncol Nurs 23 142 151
27. M Huschka K Burger 2006 Does QOL provide the same information as toxicity data? Curr Probl Cancer 30 244 254
28. YJ Kim JY Kim IR Choi MW Kim V Rhodes 2000 The index of nausea, vomiting and retching (Korean Translation) Korean Acad Adult Nurs 12 278 285
29. K Kobayashi Y Ishihara N Nukariya H Niitani H Furue Joint Research Group for Tropisetron Double-Blind Comparative Study 1999 Effects of an antiemetic drug (Tropisetron) on a quality of life during chemotherapy: use of a diary-type questionnaire and application of summary measures for assessment in a randomized, multicentre study Respirology 4 229 238
30. B Lebeau A Depierre M Giovanni A Riviere L Kaluzinski B Votan M Hédouin H d'Allens 1997 The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy Ann Oncol 8 887 892
31. CM Lindley JD Hirsch CV O'Neill MC Transau CS Gilbert JT Osterhaus 1992 Quality of life consequences of chemotherapy-induced emesis Qual Life Res 1 331 340
32. LH Lo LL Hayman 1999 Parents associated with children in measuring acute and delayed nausea and vomiting Nurs Health Sci 1 155 161
33. A Martin J Pearson B Cai M Elmer K Horgan CM Lindley 2000 Validation of a 5-day recall version of the Functional Living Index-Emesis (FLIE) quality of life questionnaire for chemotherapy-induced emesis Qual Life Res 9 18
34. AR Martin JD Pearson B Cai M Elmer K Horgan C Lindley 2003 Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall Support Care Cancer 11 522 527
35. AR Martin AD Carides JD Pearson M Elmer C Schmidt B Cai SM Grunberg 2003 Functional relevance of antiemetic control-experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant Eur J Cancer 39 1395 1401
36. CG Martin EB Rubenstein LS Elting YJ Kim D Osoba 2003 Measuring chemotherapy-induced nausea and emesis. Psychometric properties of a quality of life questionnaire Cancer 98 645 655
37. M Miller N Kearney 2004 Chemotherapy-related nausea and vomiting- past reflections, present practice and future management Eur J Cancer Care 13 71 81
38. Molassiotis A, Börjeson S (2006) Nausea and vomiting. In: Kearney N, Richardson A (eds) Nursing patients with cancer: principles and practice. Edinburgh, Elsevier Churchill Livingstone, pp 415-43
39. Molassiotis A, Saunders M, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C (2008) A prospective observational study of chemotherapy-induced nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 16:201-208
40. A Molassiotis PA Coventry CT Stricker C Clements B Eaby L Velders C Rittenberg RJ Gralla 2007 Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC Antiemesis Tool (MAT) J Pain Symptom Manage 34 148 159
41. A Molassiotis AM Helin R Dabbour S Hummerston 2007 The effects of P6 acupressure in the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients Comp Ther Med 15 3 7
42. A Molassiotis HP Yung BM Yam FY Chan TS Mok 2002 The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients. A randomised controlled trial Support Care Cancer 10 237 246
43. G Morrow 1984 Methodology in behavioural and psychosocial cancer research. The assessment nausea and vomiting. Past problems, current issues, and suggestions for future research Cancer 53 Suppl 2267 2278
44. G Morrow 1992 A patient report measure for the quantification of chemotherapy induced nausea and emesis: psychometric properties of the Morrow assessment of nausea and emesis (MANE) Br J Cancer 66 Suppl XIX S72 S74
45. SM Mullin DM Fletcher LS Tyler 1998 Mail-in questionnaire for monitoring nausea and vomiting in oncology outpatients Am J Health-Syst Pharm 55 1903 1906
46. IN Olver JP Matthews JF Bishop RA Smith 1994 The roles of patient and observer assessments in anti-emetic trials Eur J Cancer 30 1223 1227
47. D Osoba 1994 Lessons learned from measuring health-related quality of life in oncology J Clin Oncol 12 608 616
48. D Osoba B Zee D Warr J Latreille L Kaizer J Pater 1997 Effect of postchemotherapy nausea and vomiting on health-related quality of life Support Care Cancer 5 307 313
49. D Osoba B Zee J Pater D Warr J Latreille L Kaizer 1997 Determinants of postchemotherapy nausea and vomiting in patients with cancer J Clin Oncol 15 116 123
50. S Poli-Bigelli J Rodrigues-Pereira AD Carides JM Guoguang K Eldridge A Hipple JK Evans KJ Horgan F Lawson 2003 Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: Results form a randomized, double-blind, placebo-controlled trial in Latin America Cancer 97 3090 3097
51. CA Presant 1984 Quality of life in cancer patients. Who measures what? Am J Clin Oncol 7 571 573
52. VA Rhodes PM Watson MH Johnson 1984 Development of reliable and valid measures of nausea and vomiting Cancer Nurs 7 33 41
53. Rhodes VA, McDaniel RW (1997) Measuring nausea, vomiting and retching. In: Frank-Stromborg M, Olsen SJ (eds) Instruments for clinical health-care research,. 2nd edn. Jones & Bartlett, Boston, pp 509-518
54. VA Rhodes RW McDaniel 1999 The index of nausea, vomiting, and retching: a new format of the lndex of nausea and vomiting Oncol Nurs Forum 26 889 894
55. JA Roscoe GR Morrow JT Hickok RM Stern 2000 Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices J Pain Symptom Manage 20 113 121
56. L Sarna 1998 Effectiveness of structured nursing assessment of symptom distress in advanced lung cancer Oncol Nurs Forum 25 1041 1048
57. A Satou T Yamazaki N Nukariya M Nakamachi K Shimada M Matsukawa M Kurihara 2002 Development of a Japanese version of the FLIE Japanese Journal of Cancer and Chemotherapy 28 281 291
58. H Schipper J Clinch A McMurray M Levitt 1984 Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation J Clin Oncol 2 472 483
59. L Schwartzberg 2006 Chemotherapy-induced nausea and vomiting: state of the art in 2006 J Support Oncol 4 3 8
60. HS Smith 2005 A receptor-based paradigm of nausea and vomiting J Cancer Pain Symptom Pall 1 11 23
61. DL Streiner 1993 A checklist for evaluating the usefulness of rating scales Can J Psychiatry 38 140 148
62. Streiner DL, Norman GR (1995) Health measurement scales: a practical guide to their development and use, 2nd edn. Oxford University Press, New York
63. AJ Sykes AE Kiltie AL Stewart 1997 Ondasetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy Support Care Cancer 5 500 503